GeneDx Holdings Corp vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? GeneDx Holdings Corp trades at $82.37 (market cap $2.44B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $39.48. Which is the better fit depends on your goals.
| WGS | XDTE | |
|---|---|---|
Market Cap | $2.44B | — |
Sector | Technology | Income / Options Overlay |
52-Week High | $167.51 | $44.76 |
52-Week Low | $34.51 | $36.00 |
Enterprise Value | $2.48B | — |
Signals from Pluang's Aura AI — not financial advice
GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.
Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.
XDTE trades at $39.48, up 0.03% with a bullish technical signal from moving averages, though RSI indicates potential overbought conditions. The ETF focuses on weekly income via covered calls on the S&P 500, with recent dividends averaging around $0.15 per week. Financial ratios are not disclosed, and news highlights high yield claims but questions sustainability.
Outlook hinges on income strategy appeal amid market stability; opportunities include consistent payouts, but risks involve NAV erosion and fee drag. Investor caution is warranted due to mixed sentiment and reliance on options premiums.
Trailing returns across standard periods
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →